Products for Research Use Only
RegisterLogin

Rapirosiran

CAT: 0804-HY-164221Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-164221Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Rapirosiran is a N-acetylgalactosamine-conjugated small-interfering RNA targeting liver-expressed hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) mRNA. Loss-of-function variants in the HSD17B13 associated with reduced risk of chronic liver disease. Rapirosiran can be used for the study of Non-alcoholic steatohepatitis.
CAS Number
2755196-97-3
Product Name Alternative
ALN-HSD; ALN-288996; AD-288996
UNSPSC
12352211
Target
17β-HSD
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Smiles
[Rapirosiran]
Molecular Formula
C530H719F7N171O323P43S6
Molecular Weight
16307.22
References & Citations
[1]Sanyal AJ, Taubel J, Badri P, et al. Phase I randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction-associated steatohepatitis. J Hepatol. 2025;83 (4) :838-848.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported

Alternative Products

CatalogName
GTR19277205-01Rapirosiran
GTR19277165-01Rapirosiran sodium

Popular Products